Your browser doesn't support javascript.
loading
Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.
Can Bostan, Ozge; Duran, Emine; Tuncay, Gulseren; Cihanbeylerden, Melek; Karadag, Omer; Damadoglu, Ebru; Karakaya, Gul; Kalyoncu, Ali F.
Afiliação
  • Can Bostan O; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey.
  • Duran E; Department of Internal Medicine, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
  • Tuncay G; School of Medicine, Hacettepe University, Vasculitis Research Centre, Ankara, Turkey.
  • Cihanbeylerden M; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey.
  • Karadag O; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey.
  • Damadoglu E; Department of Internal Medicine, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
  • Karakaya G; School of Medicine, Hacettepe University, Vasculitis Research Centre, Ankara, Turkey.
  • Kalyoncu AF; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey.
J Asthma ; 60(5): 931-937, 2023 05.
Article em En | MEDLINE | ID: mdl-35912568

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Síndrome de Churg-Strauss / Granulomatose com Poliangiite Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Síndrome de Churg-Strauss / Granulomatose com Poliangiite Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article